These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38957975)

  • 1. High-Sensitivity Troponin T, NT-proBNP, and Cognitive Outcomes in SPRINT.
    Haney D; Ma Y; Dalmacy D; Pajewski NM; Hajjar I; de Lemos JA; Zhang W; Soliman EZ; Ballantyne CM; Nambi V; Sattar N; Killeen AA; Ix JH; Shlipak MG; Berry JD; Ascher SB
    Hypertension; 2024 Sep; 81(9):1956-1965. PubMed ID: 38957975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial.
    Kazibwe R; Ahmad MI; Hughes TM; Chen LY; Soliman EZ
    Am Heart J; 2024 Oct; 276():31-38. PubMed ID: 39067559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT.
    Ascher SB; Scherzer R; de Lemos JA; Estrella MM; Jotwani VK; Garimella PS; Bullen AL; Ambrosius WT; Ballantyne CM; Nambi V; Killeen AA; Ix JH; Shlipak MG; Berry JD
    J Am Heart Assoc; 2022 Mar; 11(6):e023314. PubMed ID: 35243872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT.
    Berry JD; Chen H; Nambi V; Ambrosius WT; Ascher SB; Shlipak MG; Ix JH; Gupta R; Killeen A; Toto RD; Kitzman DW; Ballantyne CM; de Lemos JA
    Circulation; 2023 Jan; 147(4):310-323. PubMed ID: 36533535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Ambulatory Blood Pressure Measurements With High-Sensitivity Troponin and Natriuretic Peptide Levels in SPRINT.
    Venishetty N; Berry JD; de Lemos JA; Wu E; Lee M; Drawz PE; Nambi V; Ballantyne CM; Killeen AA; Ix JH; Shlipak MG; Ascher SB
    Am J Hypertens; 2024 Jul; 37(8):571-579. PubMed ID: 38554284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change.
    Pokharel Y; Mouhanna F; Schneider ALC; Rawlings AM; Knopman DS; Nambi V; Virani SS; Hoogeveen RC; Alonso A; Heiss G; Coresh J; Mosley T; Gottesman R; Selvin E; Ballantyne C; Power MC
    J Am Geriatr Soc; 2019 Nov; 67(11):2353-2361. PubMed ID: 31359423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.
    Berry JD; Nambi V; Ambrosius WT; Chen H; Killeen AA; Taylor A; Toto RD; Soliman EZ; McEvoy JW; Pandey A; Joshi PH; Blankenberg S; Kitzman DW; Ballantyne CM; de Lemos JA
    JAMA Cardiol; 2021 Dec; 6(12):1397-1405. PubMed ID: 34468696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
    Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
    Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.
    Pandey A; Patel KV; Vongpatanasin W; Ayers C; Berry JD; Mentz RJ; Blaha MJ; McEvoy JW; Muntner P; Vaduganathan M; Correa A; Butler J; Shimbo D; Nambi V; deFilippi C; Seliger SL; Ballantyne CM; Selvin E; de Lemos JA; Joshi PH
    Circulation; 2019 Dec; 140(25):2076-2088. PubMed ID: 31707797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study).
    Madan N; Lee AK; Matsushita K; Hoogeveen RC; Ballantyne CM; Selvin E; McEvoy JW
    Am J Cardiol; 2019 Jul; 124(2):245-252. PubMed ID: 31088661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the Impact of Biomarker-Guided Versus ASCVD Risk-Guided Drug Treatment in US Adults With Stage 1 Hypertension: The National Health and Nutrition Examination Survey, 1999 to 2004.
    Foti K; Wang D; Tang O; Daya NR; Commodore-Mensah Y; Juraschek SP; Christenson RH; Selvin E; McEvoy JW
    Hypertension; 2024 Jul; 81(7):1599-1608. PubMed ID: 38690651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline, Cerebrovascular Disease, and Clinical Events.
    Gyanwali B; Lai MKP; Lui B; Liew OW; Venketasubramanian N; Richards AM; Chen C; Hilal S
    Stroke; 2021 Jul; 52(7):2275-2283. PubMed ID: 33971742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients.
    Chen JR; Wang Q; Wu W; Zhang SJ
    Clin Interv Aging; 2019; 14():81-90. PubMed ID: 30643397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).
    Seliger SL; de Lemos J; Neeland IJ; Christenson R; Gottdiener J; Drazner MH; Berry J; Sorkin J; deFilippi C
    JACC Heart Fail; 2015 Jun; 3(6):445-455. PubMed ID: 25982111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
    Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
    Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated Pulse Wave Velocity and Cognitive Outcomes: A Post hoc Analysis of SPRINT-MIND.
    Hao P; Feng S; Suo M; Wang S; Zheng K; Wu X
    Am J Hypertens; 2024 Jun; 37(7):485-492. PubMed ID: 38488616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT.
    Ascher SB; Berry JD; Katz R; de Lemos JA; Bansal N; Garimella PS; Hallan SI; Wettersten N; Jotwani VK; Killeen AA; Ix JH; Shlipak MG
    Am J Kidney Dis; 2024 May; 83(5):615-623.e1. PubMed ID: 37992982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study.
    Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
    Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of N-terminal pro-B-type natriuretic peptide in determining antihypertensive benefit: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Welsh P; Poulter NR; Chang CL; Sever PS; Sattar N;
    Hypertension; 2014 Mar; 63(3):507-13. PubMed ID: 24324046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-Sectional Associations Between Cardiac Biomarkers, Cognitive Performance, and Structural Brain Changes Are Modified by Age.
    Veugen MGJ; Henry RMA; Brunner-La Rocca HP; Dagnelie PC; Schram MT; van Agtmaal MJM; van der Kallen CJH; Sep SJS; van Boxtel MPJ; Bekers O; Meex SJR; Jansen JFA; Kroon AA; Stehouwer CDA
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1948-1958. PubMed ID: 29954754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.